Sam Brusco, Associate Editor03.29.22
Global healthcare solutions firm Owens & Minor closed the $1.6 billion acquisition of Apria Inc. that it began in January.
Owens & Minor’s existing Byram Healthcare business will combine with Apria to create an enhanced experience. The new business will feature a broad portfolio of complementary products for patients with chronic and non-chronic ailments as well as an expanded product delivery and distribution model.
“We are excited to finalize the acquisition and for Apria to become part of Owens & Minor,” Edward A. Pesicka, president and CEO of Owens & Minor told the press. “Apria is a perfect complement to our Byram business. This portfolio expansion strengthens Owens & Minor’s position in the fast-growing home health industry and enhances our ability to support healthcare beyond the hospital for both new and existing patients.”
Adding Apria forms a new Patient Direct segment with a strong commercial team across a wider geographical reach. Owens & Minor’s home healthcare portfolio will also now cover diabetes, ostomy, incontinence, wound care, home respiratory, obstructive sleep apnea, and negative pressure wound therapy.
The company aims to create a more efficient, single-source home healthcare delivery and distribution model to support care transition from hospital to home. Apria CEO Daniel J. Starck will lead the new business segment.
“We look forward to unleashing the full potential of our teammates in the new Patient Direct segment to achieve even better clinical connectivity between the patient, the provider and the payor,” Starck told the press.
“Owens & Minor continues to build momentum in the healthcare industry, expanding our Americas-based PPE and surgical product manufacturing and now accelerating our leadership position in home healthcare,” added Pesicka. “We welcome our newest teammates from Apria and look forward to continued success in our Mission of Empowering Our Customers to Advance Healthcare.”
Owens & Minor’s existing Byram Healthcare business will combine with Apria to create an enhanced experience. The new business will feature a broad portfolio of complementary products for patients with chronic and non-chronic ailments as well as an expanded product delivery and distribution model.
“We are excited to finalize the acquisition and for Apria to become part of Owens & Minor,” Edward A. Pesicka, president and CEO of Owens & Minor told the press. “Apria is a perfect complement to our Byram business. This portfolio expansion strengthens Owens & Minor’s position in the fast-growing home health industry and enhances our ability to support healthcare beyond the hospital for both new and existing patients.”
Adding Apria forms a new Patient Direct segment with a strong commercial team across a wider geographical reach. Owens & Minor’s home healthcare portfolio will also now cover diabetes, ostomy, incontinence, wound care, home respiratory, obstructive sleep apnea, and negative pressure wound therapy.
The company aims to create a more efficient, single-source home healthcare delivery and distribution model to support care transition from hospital to home. Apria CEO Daniel J. Starck will lead the new business segment.
“We look forward to unleashing the full potential of our teammates in the new Patient Direct segment to achieve even better clinical connectivity between the patient, the provider and the payor,” Starck told the press.
“Owens & Minor continues to build momentum in the healthcare industry, expanding our Americas-based PPE and surgical product manufacturing and now accelerating our leadership position in home healthcare,” added Pesicka. “We welcome our newest teammates from Apria and look forward to continued success in our Mission of Empowering Our Customers to Advance Healthcare.”